Hematology

Resource Center

News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Podcasts Q&As
Interactive
Polls Quizzes
Events & Education
ASH Annual Meeting

Featured

Conference Coverage
Drs Mikhael and Watson
Conference Coverage
Video Recap—Multiple Myeloma Across the Care Continuum
08/13/2026
Brittany Watson, MD, MPH; Joseph Mikhael, MD, MEd, FRCPC
In this video, Brittany Watson, MD, MPH, FAAFP, DABOM and Joseph Mikhael, MD, MEd, FRCPC, FACP, discuss the role of primary care in the early recognition and diagnosis of multiple myeloma, including the...
08/13/2026
FAQ
doctor talking to patient
FAQ
Hemophilia B in Primary Care: 5 Key Questions About Recognition, Diagnosis, and Management
08/10/2026
Primary care physicians can help identify previously unrecognized hemophilia B, respond appropriately to bleeding and procedural risks, reinforce hematology-directed treatment plans, and support patients...
08/10/2026
Research Summary
person taking medication
Research Summary
Aspirin Alone Noninferior to Rivaroxaban Followed by Aspirin After Hip or Knee Arthroplasty
08/06/2026
Anthony Calabro, MA
In the double-blind EPCAT III RCT, aspirin alone was noninferior to 5 days of rivaroxaban followed by aspirin for preventing symptomatic VTE after total hip or knee arthroplasty, with no clinically relevant...
08/06/2026

Interactive Features

Pop Quiz
blood drawing
Pop Quiz
Diagnosing Hemophilia B in Primary Care
08/03/2026
Anthony Calabro, MA
Test your knowledge of the diagnostic workup for hemophilia B, including why routine coagulation studies may not exclude mild disease and which laboratory test is required to confirm factor IX deficiency. ...
08/03/2026
Photoclinic Challenge
Infant with a 5 × 5 × 2 cm, well-circumscribed, violaceous lesion on the right posterior thigh
Photoclinic Challenge
Fully Formed at Birth: A Neonatal Vascular Lesion Challenge Case Description
03/28/2026
Ashton L. Stahl
A full-term newborn presents with a fully formed, violaceous vascular lesion at birth. With imaging revealing mixed vascular flow and no postnatal proliferation, can you distinguish this rare entity from...
03/28/2026
Pop Quiz
Pop Quiz
Pop Quiz
Understanding Richter Transformation in Chronic Lymphocytic Leukemia
10/14/2025
Miranda Manier, BA
Richter transformation of chronic lymphocytic leukemia carries poor outcomes with traditional therapies, but emerging treatments may improve survival. Test your knowledge of prognosis by taking this quick...
10/14/2025
Pop Quiz
Myelofibrosis
Pop Quiz
Which JAK Inhibitor Remains the Standard of Care in Myelofibrosis?
09/25/2025
Miranda Manier, BA
In an interview with Consultant360, Junaid Anwar, MD, a hematology-oncology fellow at UT Health Houston, reviewed the current evidence base for JAK inhibitors in myelofibrosis from a pooled analysis of five...
09/25/2025
Pop Quiz
pop quiz
Pop Quiz
A Serious Complication of Chronic Lymphocytic Leukemia
08/13/2025
Anthony Calabro, MA
The survival outcomes for patients diagnosed with this chronic lymphocytic leukemia complication have remained poor for decades. Can you name the complication? Take the quiz to find out!
08/13/2025

Clinical Insights

Sponsored Video
Tim F and Dr Haddad
Sponsored Video
Myelofibrosis Caregiver Interview Series: Caregiver Input for Myelofibrosis Treatment Plans
06/08/2026
Fadi G. Haddad, MD
In the final installment of the Myelofibrosis Caregiver Interview Series, Fadi Haddad, MD interviews Tim F., a caregiver from Pittsburgh, PA, about the critical role caregivers play in shared...
06/08/2026
Sponsored
Tim F.
Sponsored
Myelofibrosis Caregiver Interview Series: The Impact of Myelofibrosis on Caregivers
05/18/2026
Fadi G. Haddad, MD
In the latest installment of the Myelofibrosis Caregiver Interview Series, Tim F. from Pittsburgh, PA, talks with Fadi Haddad, MD about the caregiver perspective, highlighting the substantial day-to-day...
05/18/2026
Sponsored
Fadi Haddad, MD
Sponsored
Myelofibrosis Caregiver Interview Series: Involving Patients and Caregivers in Myelofibrosis Treatment Plans
05/06/2026
Fadi G. Haddad, MD
In the next installment of the Myelofibrosis Caregiver Interview Series, Fadi Haddad, MD, emphasizes a patient- and caregiver-centered approach to treatment planning—highlighting how clinical decisions...
05/06/2026
Sponsored
Tim F. and Fadi Haddad, MD
Sponsored
Myelofibrosis Caregiver Interview Series: Monitoring Myelofibrosis Treatment Effectiveness
04/21/2026
Fadi G. Haddad, MD
Monitoring treatment response in myelofibrosis requires a balanced assessment of patient-reported symptoms, objective scoring tools, hematologic parameters, and spleen size. In part 1 of this Myelofibrosis...
04/21/2026
Expert Q&A
Brady L Stein, MD
Expert Q&A
How the ASH Clinical Practice Guidelines Aim to Improve Myelofibrosis Management
12/22/2025
Brady L. Stein, MD
At the 2025 American Society of Hematology (ASH) Annual Meeting, Brady Stein, MD, chaired a session introducing the forthcoming ASH Clinical Practice Guidelines on Myelofibrosis—the first ASH-supported...
12/22/2025